The Asian Pacific association for the study of the liver clinical practice guidelines for the diagnosis and management of metabolic dysfunction-associated fatty liver disease.

Eslam, MohammedMohammedEslamFan, Jian-GaoJian-GaoFanYu, Ming-LungMing-LungYuWong, Vincent Wai-SunVincent Wai-SunWongCua, Ian HomerIan HomerCuaCHUN-JEN LIUTanwandee, TawesakTawesakTanwandeeGani, RinoRinoGaniSeto, Wai-KayWai-KaySetoAlam, ShahinulShahinulAlamYoung, Dan YockDan YockYoungHamid, SaeedSaeedHamidZheng, Ming-HuaMing-HuaZhengKawaguchi, TakumiTakumiKawaguchiChan, Wah-KheongWah-KheongChanPayawal, DianaDianaPayawalTan, Soek-SiamSoek-SiamTanGoh, George Boon-BeeGeorge Boon-BeeGohStrasser, Simone ISimone IStrasserViet, Hang DaoHang DaoVietJIA-HORNG KAOKim, WonWonKimKim, Seung UpSeung UpKimKeating, Shelley EShelley EKeatingYilmaz, YusufYusufYilmazKamani, LubnaLubnaKamaniWang, Chia-ChiChia-ChiWangFouad, YasserYasserFouadAbbas, ZaighamZaighamAbbasTreeprasertsuk, SombatSombatTreeprasertsukThanapirom, KessarinKessarinThanapiromAl Mahtab, MamunMamunAl MahtabLkhagvaa, UndramUndramLkhagvaaBaatarkhuu, OidovOidovBaatarkhuuChoudhury, Ashok KumarAshok KumarChoudhuryStedman, Catherine A MCatherine A MStedmanChowdhury, AbhijitAbhijitChowdhuryDokmeci, A KadirA KadirDokmeciWang, Fu-ShengFu-ShengWangLin, Han-ChiehHan-ChiehLinHuang, Jee-FuJee-FuHuangHowell, JessJessHowellJia, JidongJidongJiaAlboraie, MohamedMohamedAlboraieRoberts, Stuart KStuart KRobertsYoneda, MasatoMasatoYonedaGhazinian, HasmikHasmikGhazinianMirijanyan, AramAramMirijanyanNan, YueminYueminNanLesmana, Cosmas Rinaldi AdithyaCosmas Rinaldi AdithyaLesmanaAdams, Leon ALeon AAdamsShiha, GamalGamalShihaKumar, ManojManojKumarÖrmeci, NecatiNecatiÖrmeciWei, LaiLaiWeiLau, GeorgeGeorgeLauOmata, MasaoMasaoOmataSarin, Shiv KShiv KSarinGeorge, JacobJacobGeorge2025-05-062025-05-062025-04https://scholars.lib.ntu.edu.tw/handle/123456789/728864Metabolic dysfunction-associated fatty liver disease (MAFLD) affects over one-fourth of the global adult population and is the leading cause of liver disease worldwide. To address this, the Asian Pacific Association for the Study of the Liver (APASL) has created clinical practice guidelines focused on MAFLD. The guidelines cover various aspects of the disease, such as its epidemiology, diagnosis, screening, assessment, and treatment. The guidelines aim to advance clinical practice, knowledge, and research on MAFLD, particularly in special groups. The guidelines are designed to advance clinical practice, to provide evidence-based recommendations to assist healthcare stakeholders in decision-making and to improve patient care and disease awareness. The guidelines take into account the burden of clinical management for the healthcare sector.en[SDGs]SDG3The Asian Pacific association for the study of the liver clinical practice guidelines for the diagnosis and management of metabolic dysfunction-associated fatty liver disease.journal article10.1007/s12072-024-10774-340016576